Diabetes News

A study of the metabolic effects of omega-3 fatty acids concludes that these compounds may have an even wider range of biological impacts than previously considered, and suggests they could be of significant value in the prevention of fatty liver disease.

Good news on preserving vision in people with type 1 diabetes, a warning from the Cardiovascular Health Study for macular degeneration patients, and a report on how vision impacts well-being across the lifespan.

The risks of developing type 2 diabetes for South Asians - long known to suffer from substantially higher rates of diabetes and heart disease...

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with short-acting human insulin.

Reduced blood concentrations of adiponectin appear to indicate a significant risk of cardiovascular disease in a study focusing on risk of the disorder among patients with Type 1 diabetes.

Mayo Clinic researchers report a trend toward overtesting patients with type 2 diabetes, resulting in increased cost, time and potential overtreatment with drugs. In...

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans.

For patients undergoing kidney transplantation, treatment with the anti-rejection drug sirolimus may lead to an increased risk of diabetes.

Elevated blood levels of two inflammatory substances seem to be independent risk factors for type 2 diabetes, researchers report.

New findings in clinical and basic science transplantation research to be presented; results of a study that treated diabetic children with a combination of cells from a pig’s pancreas and testes, and findings from three separate studies with a common goal in mind: to wean organ transplant patients off all anti-rejection drugs less than one year after transplantation, defying the tenet that such drugs are required for life.

Researchers tested a compound that eliminated the incidence of diabetes and minimized insulitis, which is the inflammation associated with, and destroyer of, insulin-producing cells....

For type 2 diabetics - especially those over age 50 - the negative impact of side effects like weight gain and burdens like frequent insulin shots trumps the benefits of drugs.

Using patented Cholestosomes developed in the McCourt/Mielnicki lab, researchers have successfully encapsulated insulin, which means insulin shots could be replaced with a pill. Every day,...

Results portend first major advance for type 1 diabetics since insulin was discovered. New study shows that liraglutide reduces the wide swings in blood glucose numbers that characterize even well-controlled type 1 diabetes.

In a study that is believed to be the first in the world to evaluate the effectiveness of Qigong and Tai Chi to combat the disease, PhD student Liu Xin has developed a series of exercises to reduce the risk of progression to Type 2 diabetes.

A blood pressure medicine's success at lowering pressure shouldn't be the only measure of its effectiveness, say researchers from Wake Forest University Baptist Medical Center and colleagues in an editorial in this week's Annals of Internal Medicine.